Interagency Coordinating Committee on the Validation of Alternative Methods; Notice of Public Webcast; Request for Public Input, 21256-21257 [2020-08017]
Download as PDF
<![CDATA[
21256
Federal Register / Vol. 85, No. 74 / Thursday, April 16, 2020 / Notices
Research Training and Medical
Education, NIH Clinical Center,
National Institutes of Health, 10 Center
Drive, Room 1N252C, Bethesda, MD
20892–1158, or call non-toll-free
number (301) 496–2636, or Email your
request, including your address to:
robert.lembo@nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
SUPPLEMENTARY INFORMATION:
applicants’ qualifications to determine
applicants’ eligibility for training
programs managed by the Office.
Applicants must provide the required
information requested in the respective
applications to be considered a
candidate for participation. Information
submitted by candidates for training
programs is reviewed initially by
OCRTME administrative staff to
establish eligibility for participation.
Eligible candidates are then referred to
the designated training program
director/administrator or training
program selection committee for review
and decisions regarding acceptance for
participation. A secondary objective of
the application process is to track
enrollment in training programs over
time.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours 333.
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title:
Application Process for Clinical
Research Training and Medical
Education at the NIH Clinical Center,
Revision OMB #0925–0698, Expiration
date July 31, 2020, National Institutes of
Health Clinical Center (CC), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The primary objective of the
application process is to allow the
Office of Clinical Research Training and
Medical Education (OCRTME) at the
NIH Clinical Center to evaluate
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hours
Type of respondents
Clinical Electives Program ................
Graduate Medical Education ............
Medical Research Scholars Program
Resident Electives Program .............
Bioethics Fellowship Program ..........
Pre Doctoral Students ......................
Physicians ........................................
Pre Doctoral Students ......................
Physicians ........................................
Pre Doctoral, Post-Doctoral .............
300
100
200
100
300
1
1
1
1
1
20/60
20/60
20/60
20/60
20/60
100
33
67
33
100
Total ...........................................
...........................................................
1,000
........................
........................
333
Dated: April 10, 2020.
Laura M. Lee,
Project Clearance Liaison, NIH Clinical
Center, National Institutes of Health.
[FR Doc. 2020–08016 Filed 4–15–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee
on the Validation of Alternative
Methods; Notice of Public Webcast;
Request for Public Input
AGENCY:
National Institutes of Health,
HHS.
ACTION:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Form name
Notice.
The Interagency Coordinating
Committee on the Validation of
Alternative Methods (ICCVAM) will
hold a public forum to share
information and facilitate direct
communication of ideas and suggestions
from stakeholders. Interested persons
SUMMARY:
VerDate Sep<11>2014
18:20 Apr 15, 2020
Jkt 250001
may view the presentations by webcast.
Time will be set aside for questions and
public statements on the topics
discussed. Registration is required for
both webcast viewing and oral
statements. Information about the
meeting and registration are available at
https://ntp.niehs.nih.gov/go/
iccvamforum-2020.
DATES:
Webcast: May 21, 2020, 9:00 a.m. to
approximately 3:00 p.m. EDT.
Registration for Webcast: April 17,
2020, until 3:00 p.m. EDT May 21, 2020.
Registration for Oral Statements:
April 17, 2020, until 4:00 p.m. EDT May
8, 2020.
Registration to view the webcast and
present oral public statements is
required.
ADDRESSES:
Meeting web page: A preliminary
agenda will be posted by May 1 at
https://ntp.niehs.nih.gov/go/
iccvamforum-2020.
Webcast: The meeting will be
webcast; information to connect to the
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
webcast will be provided to those who
register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr.
Nicole Kleinstreuer, Acting Director,
National Toxicology Program
Interagency Center for the Evaluation of
Alternative Toxicological Methods
(NICEATM), Division of NTP, NIEHS,
P.O. Box 12233, K2–17, Research
Triangle Park, NC 27709. Phone: 984–
287–3150, Email: nicole.kleinstreuer@
nih.gov. Hand Deliver/Courier address:
530 Davis Drive, Room K2021,
Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM, a
congressionally mandated committee,
promotes the development and
validation of alternative testing
strategies that protect human health and
the environment while replacing,
reducing, or refining animal use.
ICCVAM’s goals include promotion of
national and international partnerships
between governmental and
nongovernmental groups, including
academia, industry, advocacy groups,
and other key stakeholders. To foster
E:\FR\FM\16APN1.SGM
16APN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 74 / Thursday, April 16, 2020 / Notices
these partnerships ICCVAM initiated
annual public forums in 2014 to share
information and facilitate direct
communication of ideas and suggestions
from stakeholders (79 FR 25136).
This year’s meeting will be held on
May 21, 2020. Due to restrictions on inperson gatherings amid ongoing public
health concerns, the public forum will
be presented via webcast only.
NICEATM and ICCVAM members will
give presentations on current activities
related to the development and
validation of alternative test methods
and approaches, including activities
relevant to implementation of the
strategic roadmap for establishing new
approaches to evaluate the safety of
chemicals and medical products in the
United States (83 FR 7487).
There will be opportunities for
registered participants to ask clarifying
or follow-up questions of the ICCVAM
members about their presentations.
Instructions for submitting these
questions will be provided via email
prior to the webcast. The agenda will
also include time for public oral
statements relevant to the ICCVAM
mission and current activities from
participants who have registered to do
so in advance.
Preliminary Agenda and Other
Meeting Information: A preliminary
agenda will be posted by May 1 at
https://ntp.niehs.nih.gov/go/
iccvamforum-2020. Interested
individuals are encouraged to visit this
web page to stay abreast of the most
current meeting information.
Webcast and Registration: This
webcast is open to the public.
Registration for the webcast is required
and is open through 3:00 p.m. EDT on
May 21, 2020 at https://
ntp.niehs.nih.gov/go/commprac-2020.
Registrants will receive instructions on
how to access and participate in the
webcast in the email confirming their
registration.
Individuals with disabilities who
need accommodation to participate in
this event should contact Elizabeth
Maull at phone: (984) 287–3157 or
email: maull@niehs.nih.gov. TTY users
should contact the Federal TTY Relay
Service at (800) 877–8339. Requests
should be made at least five business
days in advance of the event.
Request for Oral Public Statements: In
addition to time for clarifying or followup questions following scheduled
presentations, time will be allotted
during the meeting for oral public
statements with associated slides on
topics relevant to ICCVAM’s mission.
Separate registration for those wishing
to provide public statements is required
and is open through May 8, 2020 at
VerDate Sep<11>2014
18:20 Apr 15, 2020
Jkt 250001
https://ntp.niehs.nih.gov/go/commprac2020. Any participant registered for the
webcast may ask clarifying questions
during the appropriate times in the
agenda. The additional registration is
only required for those who wish to give
separate public statements. The number
and length of presentations may be
limited based on available time.
Submitters will be identified by their
name and affiliation and/or sponsoring
organization, if applicable. Persons
submitting public statements and/or
associated slides should include their
name, affiliation (if any), mailing
address, telephone, email, and
sponsoring organization (if any) with
the document. National Toxicology
Program guidelines for public
statements are at https://
ntp.niehs.nih.gov/ntp/about_ntp/
guidelines_public_comments_508.pdf.
Participants registered to present oral
public statements must email their
statement to ICCVAMquestions@
niehs.nih.gov by May 8, 2020, to allow
time for review by NICEATM and
ICCVAM and posting to the meeting
page prior to the forum. Persons
presenting oral public statements will
be contacted to arrange the logistics of
their presentations. Written statements
may supplement and expand the oral
presentation. Public statements will be
distributed to NICEATM and ICCVAM
members before the meeting.
Responses to this notice are
voluntary. No proprietary, classified,
confidential, or sensitive information
should be included in statements
submitted in response to this notice or
presented during the meeting. This
request for input is for planning
purposes only and is not a solicitation
for applications or an obligation on the
part of the U.S. Government to provide
support for any ideas identified in
response to the request. Please note that
the U.S. Government will not pay for
the preparation of any information
submitted or for its use of that
information.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 16 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability and promotes
the scientific validation and regulatory
acceptance of testing methods that more
accurately assess the safety and hazards
of chemicals and products and replace,
reduce, or refine (enhance animal well-
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
21257
being and lessen or avoid pain and
distress) animal use.
The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) establishes
ICCVAM as a permanent interagency
committee of NIEHS and provides the
authority for ICCVAM involvement in
activities relevant to the development of
alternative test methods. Additional
information about ICCVAM can be
found at https://ntp.niehs.nih.gov/go/
iccvam.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,
and conducts and publishes analyses
and evaluations of data from new,
revised, and alternative testing
approaches. NICEATM and ICCVAM
work collaboratively to evaluate new
and improved testing approaches
applicable to the needs of U.S. federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative test methods
and strategies for validation studies and
technical evaluations. Additional
information about NICEATM can be
found at https://ntp.niehs.nih.gov/go/
niceatm.
Dated: April 7, 2020.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2020–08017 Filed 4–15–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2020–0006]
Homeland Security Advisory Council;
Meeting
The Office of Partnership and
Engagement (OPE), The Department of
Homeland Security (DHS).
ACTION: Notice of partially closed
teleconference Federal Advisory
Committee meeting.
AGENCY:
The Homeland Security
Advisory Council (‘‘HSAC’’ or
‘‘Council’’) will meet via conference call
on Thursday, May 7, 2020. The meeting
will be partially closed to the public.
Members of the public will be in listenonly mode during the open session.
DATES: The Council conference call will
take place from 9:15 a.m. to 12:45 p.m.
EDT on Thursday, May 7, 2020. The
meeting will be closed to the public
from 9:15 a.m. to 11:35 a.m. EDT. The
meeting will be open to the public from
11:40 a.m. to 12:45 a.m. EDT. Please
note the meeting may end early if the
Council has completed its business, and
SUMMARY:
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 85, Number 74 (Thursday, April 16, 2020)]
[Notices]
[Pages 21256-21257]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08017]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee on the Validation of
Alternative Methods; Notice of Public Webcast; Request for Public Input
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Interagency Coordinating Committee on the Validation of
Alternative Methods (ICCVAM) will hold a public forum to share
information and facilitate direct communication of ideas and
suggestions from stakeholders. Interested persons may view the
presentations by webcast. Time will be set aside for questions and
public statements on the topics discussed. Registration is required for
both webcast viewing and oral statements. Information about the meeting
and registration are available at https://ntp.niehs.nih.gov/go/iccvamforum-2020.
DATES:
Webcast: May 21, 2020, 9:00 a.m. to approximately 3:00 p.m. EDT.
Registration for Webcast: April 17, 2020, until 3:00 p.m. EDT May
21, 2020.
Registration for Oral Statements: April 17, 2020, until 4:00 p.m.
EDT May 8, 2020.
Registration to view the webcast and present oral public statements
is required.
ADDRESSES:
Meeting web page: A preliminary agenda will be posted by May 1 at
https://ntp.niehs.nih.gov/go/iccvamforum-2020.
Webcast: The meeting will be webcast; information to connect to the
webcast will be provided to those who register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr. Nicole Kleinstreuer, Acting
Director, National Toxicology Program Interagency Center for the
Evaluation of Alternative Toxicological Methods (NICEATM), Division of
NTP, NIEHS, P.O. Box 12233, K2-17, Research Triangle Park, NC 27709.
Phone: 984-287-3150, Email: [email protected]. Hand Deliver/
Courier address: 530 Davis Drive, Room K2021, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM, a congressionally mandated committee, promotes
the development and validation of alternative testing strategies that
protect human health and the environment while replacing, reducing, or
refining animal use.
ICCVAM's goals include promotion of national and international
partnerships between governmental and nongovernmental groups, including
academia, industry, advocacy groups, and other key stakeholders. To
foster
[[Page 21257]]
these partnerships ICCVAM initiated annual public forums in 2014 to
share information and facilitate direct communication of ideas and
suggestions from stakeholders (79 FR 25136).
This year's meeting will be held on May 21, 2020. Due to
restrictions on in-person gatherings amid ongoing public health
concerns, the public forum will be presented via webcast only. NICEATM
and ICCVAM members will give presentations on current activities
related to the development and validation of alternative test methods
and approaches, including activities relevant to implementation of the
strategic roadmap for establishing new approaches to evaluate the
safety of chemicals and medical products in the United States (83 FR
7487).
There will be opportunities for registered participants to ask
clarifying or follow-up questions of the ICCVAM members about their
presentations. Instructions for submitting these questions will be
provided via email prior to the webcast. The agenda will also include
time for public oral statements relevant to the ICCVAM mission and
current activities from participants who have registered to do so in
advance.
Preliminary Agenda and Other Meeting Information: A preliminary
agenda will be posted by May 1 at https://ntp.niehs.nih.gov/go/iccvamforum-2020. Interested individuals are encouraged to visit this
web page to stay abreast of the most current meeting information.
Webcast and Registration: This webcast is open to the public.
Registration for the webcast is required and is open through 3:00 p.m.
EDT on May 21, 2020 at https://ntp.niehs.nih.gov/go/commprac-2020.
Registrants will receive instructions on how to access and participate
in the webcast in the email confirming their registration.
Individuals with disabilities who need accommodation to participate
in this event should contact Elizabeth Maull at phone: (984) 287-3157
or email: [email protected]. TTY users should contact the Federal TTY
Relay Service at (800) 877-8339. Requests should be made at least five
business days in advance of the event.
Request for Oral Public Statements: In addition to time for
clarifying or follow-up questions following scheduled presentations,
time will be allotted during the meeting for oral public statements
with associated slides on topics relevant to ICCVAM's mission. Separate
registration for those wishing to provide public statements is required
and is open through May 8, 2020 at https://ntp.niehs.nih.gov/go/commprac-2020. Any participant registered for the webcast may ask
clarifying questions during the appropriate times in the agenda. The
additional registration is only required for those who wish to give
separate public statements. The number and length of presentations may
be limited based on available time. Submitters will be identified by
their name and affiliation and/or sponsoring organization, if
applicable. Persons submitting public statements and/or associated
slides should include their name, affiliation (if any), mailing
address, telephone, email, and sponsoring organization (if any) with
the document. National Toxicology Program guidelines for public
statements are at https://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf.
Participants registered to present oral public statements must
email their statement to [email protected] by May 8, 2020,
to allow time for review by NICEATM and ICCVAM and posting to the
meeting page prior to the forum. Persons presenting oral public
statements will be contacted to arrange the logistics of their
presentations. Written statements may supplement and expand the oral
presentation. Public statements will be distributed to NICEATM and
ICCVAM members before the meeting.
Responses to this notice are voluntary. No proprietary, classified,
confidential, or sensitive information should be included in statements
submitted in response to this notice or presented during the meeting.
This request for input is for planning purposes only and is not a
solicitation for applications or an obligation on the part of the U.S.
Government to provide support for any ideas identified in response to
the request. Please note that the U.S. Government will not pay for the
preparation of any information submitted or for its use of that
information.
Background Information on ICCVAM and NICEATM: ICCVAM is an
interagency committee composed of representatives from 16 federal
regulatory and research agencies that require, use, generate, or
disseminate toxicological and safety testing information. ICCVAM
conducts technical evaluations of new, revised, and alternative safety
testing methods and integrated testing strategies with regulatory
applicability and promotes the scientific validation and regulatory
acceptance of testing methods that more accurately assess the safety
and hazards of chemicals and products and replace, reduce, or refine
(enhance animal well-being and lessen or avoid pain and distress)
animal use.
The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l-3) establishes
ICCVAM as a permanent interagency committee of NIEHS and provides the
authority for ICCVAM involvement in activities relevant to the
development of alternative test methods. Additional information about
ICCVAM can be found at https://ntp.niehs.nih.gov/go/iccvam.
NICEATM administers ICCVAM, provides scientific and operational
support for ICCVAM-related activities, and conducts and publishes
analyses and evaluations of data from new, revised, and alternative
testing approaches. NICEATM and ICCVAM work collaboratively to evaluate
new and improved testing approaches applicable to the needs of U.S.
federal agencies. NICEATM and ICCVAM welcome the public nomination of
new, revised, and alternative test methods and strategies for
validation studies and technical evaluations. Additional information
about NICEATM can be found at https://ntp.niehs.nih.gov/go/niceatm.
Dated: April 7, 2020.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2020-08017 Filed 4-15-20; 8:45 am]
BILLING CODE 4140-01-P
